Meldungen sortieren nach Relevanz Meldungsdatum
|
BIOTRONIK Announces Acquisition of VascoMed
01.02.2008, Medizintechnik, BIOTRONIK GmbH & Co. KG
BIOTRONIK, a leading European biomedical technology firm focusing on vascular interventions and cardiac electrotherapy, today announced the acquisition of VascoMed...
|
|
BIOTRONIK Home Monitoring for Patients with Cardiac Devices Launched in India
21.02.2008, Forschung und Entwicklung, BIOTRONIK GmbH & Co. KG
BIOTRONIK, the pioneer in remote monitoring technologies for patients with cardiac devices, has launched its revolutionary Home Monitoring® system in India. This...
|
Roche's xCELLigence RTCA Cardio Instrument Used to Estimate the Risk of Drug-induced Proarrhythmia in Human Induced Pluripotent Stem Cell Derived Cardiomyocytes
21.07.2011, Biotechnik, Roche Diagnostics GmbH
Cardiotoxicity, which results when drugs adversely affect the heart, explains why roughly one third of new pharmaceuticals are withdrawn from the market and why...
|
Medos Medizintechnik AG gets a visual makeover
08.11.2011, Medizintechnik, Medos Medizintechnik AG
Medos presented its complete design makeover for the first time at the 25th Annual European Congress of Cardiac and Thoracic Surgeons (EACTS) in Lisbon in early...
|
|
Roche's new RTCA Cardio Instrument for label-free functional cardiomyocyte toxicity testing
28.09.2010, Biotechnik, Roche Diagnostics GmbH
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it had launched the RTCA Cardio Instrument, the latest member of the xCELLigence product family. The RTCA...
|
|
Roche's xCELLigence System Monitors Beating Periodicity of Stem Cell Derived Cardiomyocytes in Preclinical Safety Assessment
15.09.2011, Forschung und Entwicklung, Roche Diagnostics GmbH
Cardiac toxicity is a major concern in drug development and it is imperative that clinical candidates are thoroughly tested for adverse effects earlier in the drug...
|
|
Jetzt gegen den Elecsys Troponin T hs Test restandardisiert: der Roche CARDIAC T Quantitative Test
05.09.2011, Biotechnik, Roche Diagnostics GmbH
Der Roche CARDIAC T Quantitative Test zur Bestimmung von Troponin T auf dem cobas h 232 POC Analysesystem wurde jetzt gegen den neuen Troponin T high sensitive (hs)...
|
|
AgenoLAB Broadens Service Offering for Drug Development with Roche's RTCA Cardio Instrument
12.05.2011, Medizintechnik, Roche Diagnostics GmbH
AgenoLAB, the Stuttgart-based service provider, is the first company in Germany to expand its service offering with the latest cell analysis technology from Roche...
|
|
Cellular Dynamics International, ACEA Biosciences, and Roche Applied Sciences Cooperate to Evaluate iCell Cardiomyocytes on the xCELLigence System
16.09.2010, Biotechnik, Roche Diagnostics GmbH
Cellular Dynamics International (CDI) announced today their partnership with ACEA Biosciences to bring early and accurate prediction of potential cardiotoxic side...
|
|
BIOTRONIK launches largest worldwide Clinical Trial using wireless Home Monitoring technologies
29.02.2008, Medizintechnik, BIOTRONIK GmbH & Co. KG
BIOTRONIK, the pioneer in remote monitoring technologies for patients with cardiac devices, announced today the launch of the landmark IMPACT Study (The IMPACT of...
|
|
First Implants of Lumax 540 Series
10.04.2008, Medizintechnik, BIOTRONIK GmbH & Co. KG
After receiving CE Mark approval last week, BIOTRONIK GmbH & Co. KG, the pioneer in wireless remote monitoring technology for patients with cardiac devices, announced...
|
|
Roche joins forces to innovate toxicity testing and to reduce animal experimentation
18.05.2009, Forschung und Entwicklung, Roche Diagnostics GmbH
Today, Roche opened the Joint Science & Technology Laboratory in Basel, where Roche Pharma scientists are using the innovative xCELLigence real-time Cell Analyzer...
|
|
BIOTRONIK Concludes Enrollment of Home Monitoring Clinical Trial Ahead of Schedule
19.03.2008, Medizintechnik, BIOTRONIK GmbH & Co. KG
BIOTRONIK, the pioneer in fully automated, remote device patient management known as Home Monitoring®, announced today that the recruitment phase of the TRUST Study...
|
|
Roche Diagnostics supports European Union's DETECTIVE Project to reduce Animal Testing
21.06.2011, Biotechnik, Roche Diagnostics GmbH
The xCELLigence RTCA System of Roche (SIX: RO, ROG; OTCQX: RHHBY) is being used in the European Union's DETECTIVE ("Detection of endpoints and biomarkers for repeated...
|
Operation gelungen - HP, Cisco und Cardiac praesentieren das "Digitale Krankenhaus"
27.03.2006, Kooperationen / Fusionen, Hewlett-Packard Deutschland GmbH
Kliniken und Krankenhaeuser stehen vor einer Vielzahl von Herausforderungen: Sie muessen die Behandlungskosten senken ohne dass die Gesundheitsversorgung darunter...
Firmen
Kategorien
Alle Kategorien
